Compare BridgeBio Pharma Inc (BBIO) vs Keysight Technologies Inc (KEYS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Keysight Technologies Inc — how do they compare? BridgeBio Pharma Inc trades at $84.09 (market cap $16.27B), while Keysight Technologies Inc trades at $325.73 (market cap $54.83B). The key difference: Keysight Technologies Inc is far larger — about 3.4× BridgeBio Pharma Inc's market cap. Which is the better fit depends on your goals.
| BBIO | KEYS | |
|---|---|---|
Market Cap | $16.27B | $54.83B |
Sector | Health | Technology |
52-Week High | $90.17 | $373.34 |
52-Week Low | $44.81 | $158.51 |
Enterprise Value | $17.82B | $55.18B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Keysight Technologies Inc
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.
Read more on KEYS →
